Kallikrein(激肽释放酶)

Cat.No. 产品名称 Information

GC71069 Kallikrein 5-IN-2 Kallikrein 5-IN-2(化合物21)是一种选择性Kallikrein KLK5抑制剂(pIC50=7.1)。

GP21837 KLK1 Human Kallikrein-1 Human Recombinant

GP21838 KLK1 Human, His Kallikrein-1 Human Recombinant, His Tag

GP21848 KLK10 Human Kallikrein-10 Human Recombinant

GP21849 KLK10 Human, Sf9 Kallikrein-10 Human Recombinant, Sf9

GP21850 KLK11 Human Kallikrein-11 Human Recombinant

GP21851 KLK11 Human, Sf9 Kallikrein-11, 4 Human Recombinant, Sf9

GP21852 KLK13 Human Kallikrein-13 Human Recombinant

GP21853 KLK13 Human, sf9 Kallikrein-13 Human Recombinant, sf9

GP21854 KLK15 Human Kallikrein-15 Human Recombinant

GP21855 KLK15 Human, sf9 Kallikrein-15 Human Recombinant, sf9

GP21839 KLK2 Human Kallikrein-2 Human Recombinant

GP21840 KLK2 Human, sf9 Kallikrein-2 Human Recombinant, sf9

GP21841 KLK3 Kallikrein-3 Human Recombinant

GP21842 KLK3 Human Kallikrein-3 Human

GP26162 KLK3 Human, HEK KLK3 Human Recombinant produced in HEK cells is a single, glycosylated, polypeptide chain (18-261 a

GP26163 KLK3 Human, Native Human Kallikrein-3 produced in Human seminal fluid having a molecular mass of approximately 30kD

GP26161 KLK3 Protein Kallikrein-3 Human Recombinant produced in E

GP21843 KLK5 Human Kallikrein-5 Human Recombinant

GP21844 KLK5 Human, Sf9 Kallikrein-5 Human Recombinant, Sf9

GP21845 KLK7 Human Kallikrein-7 Human Recombinant

GP21846 KLK7 Human, sf9 Kallikrein-7 Human Recombinant, sf9

GP21847 KLK8 Mouse Kallikrein-8 Mouse Recombinant

GC72335 Lanadelumab Lanadelumab（SHP643）是一种针对血浆激肽释放酶（pKal）的人IgG1单克隆抗体，Ki值为0.12 nM。

GC71219 Plasma kallikrein-IN-4 Plasma kallikrein-IN-4（实施例153）是一种血浆激肽释放酶抑制剂，对人血浆激肽放酶的IC50为0.016μM。